Displaying 61 - 80 of 1554
Altria Group/JUUL Labs, In the Matter of
The Federal Trade Commission filed an administrative complaint alleging that Altria Group, Inc. and JUUL Labs, Inc. entered a series of agreements, including Altria’s acquisition of a 35% stake in JUUL, that eliminated competition in violation of federal antitrust laws. According to the complaint, this series of agreements involved Altria ceasing to compete in the U.S. market for closed-system electronic cigarettes in return for a substantial ownership interest in JUUL, by far the dominant player in that market. In an initial decision announced on Feb. 24, 2022, Chief Administrative Law Judge D. Michael Chappell dismissed the antitrust charges in the complaint.
16 CFR Parts 801 and 803: Premerger Notification; Reporting and Waiting Period Requirements
FTC and DOJ Propose Changes to HSR Form for More Effective, Efficient Merger Review
FTC Policy Director Issues Statement Commending Maine’s Repeal of Certificate of Public Advantage Law
FTC Staff Opposes State Legislation in North Carolina Designed to Shield UNC Health System from Antitrust Enforcement
FTC, DOJ Issue Summary on Joint Pharmaceutical Merger Analysis Workshop
Statement Regarding the Termination of Boston Scientific Corporation’s Attempted Acquisition of a Majority Stake in M.I. Tech Co., Ltd.
Amgen Inc. and Horizon Therapeutics plc, FTC v.
FTC Sues to Block Biopharmaceutical Giant Amgen from Acquisition That Would Entrench Monopoly Drugs Used to Treat Two Serious Illnesses
Statement Regarding the Termination of CalPortland Company’s Attempted Acquisition of Assets Owned by Rival Cement Producer Martin Marietta Materials, Inc.
FTC Sues to Stop the Potentially Illegal Integration of New Orleans Area Hospitals Over Failure to Follow Federal Reporting Law
Intercontinental Exchange, Inc. and Black Knight, Inc., FTC v.
FTC Staff Seeks Court Order Preventing ICE from Consummating its Acquisition of Rival Black Knight Pending Agency Administrative Challenge
FTC, Justice Department, and European Commission Hold Third U.S.- EU Joint Technology Competition Policy Dialogue
FTC Files Amicus Brief in Sage Chemical vs. Supernus Pharmaceutical Supporting Competition in the Market for Drug Used to Treat Advanced Parkinson’s Disease
FTC and Justice Department to Hold Annual Spring Enforcers Summit
FTC Acts to Block Deal Combining the Two Top Mortgage Loan Technology Providers
Joint Statement of Chair Khan, Commissioner Slaughter, Commissioner Wilson, and Commissioner Bedoya, Regarding Amazon.com, Inc.'s Acquisition of 1Life Healthcare, Inc.
Displaying 61 - 80 of 1554